Q

Quince Therapeutics
D

QNCX

1.30000
USD
-0.05
(-3.70%)
مغلق
حجم التداول
10,892
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
67,782,923
الأخبار المقالات

العنوان: Quince Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.